Indefinite Delivery Contract W91YU015D0010
Award Date
8/20/15
Last Date to Order
9/30/20
Federal Agency
Medical Command
Awardee
Gen-Probe Incorporated
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
Coronavirus COVID-19
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV is an Indefinite Delivery Contract awarded by the Department of the Army Medical Command to Gen-Probe Incorporated, a medical diagnostics company, with a ceiling value of $2,073,793.50. Through this contract and associated delivery orders, Gen-Probe provides a variety of medical testing products and services to the Defense Health Agency, Department of Veterans Affairs, and Department of the Navy, including APTIMA combo assay test kits for chlamydia and gonorrhea,...
The Department of the Army Medical Command awarded an indefinite delivery contract to Gen-Probe Incorporated to procure COVID-19 testing supplies and reagents. Under the contract vehicle, two firm fixed price delivery orders have been issued to date totaling $35.7M. The first order, awarded in January 2021 for $16.2M, provides COVID-19 PANTHER Fusion test kits to support Army medical response efforts, with delivery to a facility in Fort Sam Houston, Texas. The second order, awarded in April 2020...
The Defense Health Agency awarded a single award Indefinite Delivery Contract to Gen-Probe Incorporated to provide COVID-19 testing services and supplies. Under the contract, Gen-Probe will supply its APTIMA SARS-COV-2 ASSAY test kits, which have received Emergency Use Authorization from the FDA. Two firm fixed price delivery orders were issued against the IDC. The first was awarded on January 27, 2022 for $552,691.20 to provide 250 APTIMA test kits for use in Marlborough, Massachusetts from...
This Indefinite Delivery Contract was awarded by the Department of the Army Medical Command to Hologic Sales And Service, LLC as a single award IDV with a potential value of $172,445,826 and a period of performance through May 2, 2024. The IDV aims to procure Panther Fusion and Aptima COVID-19 test kits to support the Medical Command's SARS-CoV-2 diagnostic testing requirements across its medical treatment facilities. Five firm fixed price delivery orders have been awarded against the IDV to...
The Department of the Navy Bureau of Medicine and Surgery, Defense Health Agency, and other agencies awarded multiple firm fixed price delivery orders against an indefinite delivery contract held by Gen-Probe Incorporated to procure COVID-19 reagents, assays, and related products. Task orders were issued between July 2020 and January 2022 for places of performance including Marlborough, MA; San Diego, CA; and Portsmouth, VA. Values ranged from $2,300 to $9,663,610 with periods of performance...
The federal contract IDV award W81K0220D0015 was issued by the Medical Command of the U.S. Department of the Army to Hologic Sales and Service, LLC, a division of Hologic, Inc., as a single-award, indefinite-delivery contract with a ceiling value of $2,934,930. The contract provides for the delivery of molecular analyzers, reagents, and related supplies to support medical testing operations at Madigan Army Medical Center in Washington through September 2025. Under this IDV, the Defense Health...
The federal contract IDV award is a Blanket Purchase Agreement (BPA) master contract between the Defense Health Agency (DHA) and Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $8,000,000 and an ultimate completion date of January 24, 2030. Under this single-award BPA, Cepheid provides the DHA with reagents, testing kits, and consumable supplies for molecular diagnostic testing. Key products include GeneXpert diagnostic systems,...
The indefinite delivery contract (IDC) with award number 75H70525D00004 was awarded by the Indian Health Service (IHS), a civilian federal agency, to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The single-award IDC has a ceiling value of $5,000,000 and a period of performance from June 17, 2025 to June 30, 2026. Under this IDC, Cepheid will provide the IHS with GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Army Medical Command (MEDCOM) to Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch, a for-profit medical equipment manufacturer and supplier. The $3,438,000 single-award contract, awarded on November 1, 2020, aims to provide COVID-19 anti SARS-CoV-2 test reagents to the Brian D. Allgood Army Community Hospital in South Korea through September 30, 2023. An initial $10,000 firm fixed price delivery order was placed on...
This federal Indefinite Delivery Contract (IDC) with a ceiling value of $49,000,000 was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract enables the continuous procurement of Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support clinical testing programs across various federal agencies, including the Department of Veterans Affairs...
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order W91YU015D0010-W81K0219F0289 | Gen-Probe Incorporated | $659.0k | 10/1/19 | 9/30/20 | 2/19/20 | |
Delivery Order W91YU015D0010-0003 | Gen-Probe Incorporated | $539.0k | 9/25/17 | 9/30/18 | 10/19/17 | |
Delivery Order W91YU015D0010-W81K0219F0018 | Gen-Probe Incorporated | $539.0k | 11/21/18 | 9/30/19 | 11/20/18 | |
Delivery Order W91YU015D0010-0001 | Gen-Probe Incorporated | $612.5k | 8/25/15 | 9/30/16 | 7/29/16 | |
Delivery Order W91YU015D0010-W81K0220F0131 | Gen-Probe Incorporated | $1.8m | 10/1/19 | 9/30/20 | 4/24/20 |